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Abstract 
This study was to investigate the antimicrobial resistance of Enterococcus spp. isolated in 8 consecutive years in the 
First Bethune Hospital. Disk diffusion test was used to study the antimicrobial resistance. The data were analyzed by 
WHONET 5 software according to Clinical and Laboratory Standards Institute (CLSI). Most of 1446 strains of 
Enterococcus spp. were collected from urine 640 (44.3%), sputum 315 (21.8%), secretions and pus 265 (18.3%) 
during the past 8 years. The rates of high-level aminoglycoside resistance in Enterococcus faecalis and Enterococcus 
faecium were 57.4 ~75.9  and 69.0%~93.8% during the past 8 years, respectively. No Enterococcus spp. was 
resistant to vancomycin. The antimicrobial resistance of Enterococcus spp. had increased in recent 8 years. The 
change of the antimicrobial resistance should be investigated in order to direct rational drug usage in the clinic and 
prevent bacterial strain of drug resistance from being transmitted. 
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1. Introduction 
During the past decade, enterococci have emerged as important causes of nosocomial and 
community-acquired infections. The seriousness of this problem can vary markedly worldwide and within 
nations. The objectives of this study were to investigate the antimicrobial resistance of Enterococcus spp. 
isolated in 8 consecutive years in the First Bethune Hospital. 
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2. Materials and methods 
2.1. Bacterial isolates 
Consecutive nonduplicate nosocomial isolates of Enterococcus spp. were collected during the period 
from 2003 to 2010 in the First Bethune Hospital. Isolates were identified at the species level using 
standard biochemical tests and microbiological methods. 
2.2. Antimicrobial susceptibility testing 
The susceptibilities of Enterococcus spp. to 11 antimicrobial agents were determined by the disk 
diffusion method in accordance with Clinical and Laboratory Standards Institute (CLSI) guidelines. 
2.3. Screening tests for high-level aminoglycoside resistance (HLAR) 
HLAR was detected using gentamicin (120 g) antibiotic disks (OXOID) by the disk diffusion test. 
Zone diameter of 6 mm is resistant and 10 mm is susceptible according to CLSI. Enterococcus faecalis 
ATCC 25212 was used as control strain.  
2.4. Screening tests for Vancomycin resistance 
Vancomycin resistance was detected using vancomycin (30 g) antibiotic disks (OXOID) by the disk 
diffusion test. Evaluation of the results was according to CLSI. Enterococcus faecalis ATCC 25212 was 
used as control strain. 
3. Results 
Distribution of specimen type: during the 8-year study period, 1446 consecutive clinical isolates of 
Enterococcus spp. were isolated in the First Bethune Hospital. The strains were cultured from urine 640 
(44.3%), sputum 315 (21.8%), secretions and pus 265 (18.3%), blood 130 (9.0%), pleural fluid and 
abdominal fluid 58 (4.0%), bile 35 (2.4%), bone marrow 38 (0.2%). 
The rates of HLAR in Enterococcus faecalis were 57.4% (35/61), 60.8% (48/79), 64.9% (52/80), 
72.3% (47/65), 72.5% (66/91), 74.7% (115/154), 75.9% (110/145), 75.4.% (132/175) from 2003 to 2010 
in the First Bethune Hospital, respectively. The rates of HLAR in Enterococcus faecium were 72.1% 
(31/43), 73.3% (33/45), 69.0% (29/42), 93.8% (61/65), 88.7% (63/71), 90.9% (90/99), 91.9% (102/111), 
91.7% (110/120) in the First Bethune Hospital. in the First Bethune Hospital, respectively. 
No Enterococcus spp. was resistant to vancomycin in the First Bethune Hospital. 
Resistance of Enterococcus faecalis and Enterococcus faecium is shown in table 1. 
4. Discussion 
Multi-resistant enterococci continues to be documented world-wide, with the greatest rates being 
observed in North America and the highest infection rates being discovered among “at-risk” patients[1-2]. 
The most frequent infections caused by enterococci are urinary tract infections, followed by 
intra-abdominal and pelvic abscesses or post-surgery wound infections[3]. The top three specimen types 
in the present study were urine, sputum, secretions and pus in the past 8 years in the First Bethune 
Hospital. It is emphasized that enterococci are mainly responsible for urinary tract infection, pneumonia 
and wound infection in the First Bethune Hospital.  
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The current study showed prevalence of HLAR in Enterococcus faecalis and Enterococcus faecium 
were 57.4 ~75.9  and 69.0%~93.8% during the past 8 years in the First Bethune Hospital. The rates 
of HLAR were much higher than those in SENTRY Antimicrobial Surveillance Program[4]. No 
Enterococcus spp. was resistant to vancomycin in the First Bethune Hospital in the First Bethune Hospital. 
It is lower than that in SENTRY Antimicrobial Surveillance Program. It is associated with different 
geography, breakpoints, or antimicrobial susceptibility testing. Clinical laboratories need to have 
adequate equipment and expertise to provide detection method for HLAR. 
In addition to excellent activity of vancomycin and teicoplanin, the resistance rates of enterococci for 
penicillin G, ampicilin, tetracycline, rifampin, ciprofloxacin, levofloxacin, gatifloxacin and erythromycin 
were almost more than 50% during 8 years in the First Bethune Hospital. The resistance rates of 
Enterococcus faecium to the most antibiotics are much higher than those of Enterococcus faecalis during 
8 years in the First Bethune Hospital. Enterococci are intrinsically resistant to many antimicrobial agents, 
including aminoglycosides, clindamycin, the anti-staphylococcal penicillins (oxacillin, methicillin, 
nafcillin), cephalosporins, and most fluoroquinolones. Antimicrobial resistance to enterococci will be a 
serious problem all over the world.  
Monitoring antibiotic use with microbiology laboratory support can promote rational drug utilization, 
cut costs and delay the emergence of resistant organisms. 
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TABLE 1   Antimicrobial resistance of enterococcus SPP. (%) 
 
1200   Jiancheng Xu et al. /  Physics Procedia  33 ( 2012 )  1197 – 1200 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: ANT: antibiotics, PEN: penicillin G, AMP: ampicilin, TCY: tetracycline, CIP: ciprofloxacin, LEV: levofloxacin, GAT: 
gatifloxacin, ERY: erythromycin, VAN: vancomycin, TEC: teicoplanin, GEN: gentamycin (120 g), RIF: rifampin  
 
 
 
ANT 
Enterococcus faecalis Enterococcus faecium 
2003 
(n=61) 
2004
(n=79)
2005 
(n=80) 
2006 
(n=65) 
2007 
(n=91) 
2008
(n=154)
2009
(n=145)
2010
(n=175)
  2003
(n=43) 
2004
(n=45) 
2005
(n=42) 
2006
(n=65) 
2007
(n=71) 
2008 
(n=99) 
2009 
(n=111) 
2010 
(n=120) 
PEN 49.2 50.6 50.0 60.0 60.4 64.9 66.2 68.6 81.4 82.2 84.2 93.8 95.8 96.0 94.6 96.7 
AMP 49.2 50.6 50.0 60.0 60.4 64.9 66.2 68.6 81.4 82.2 84.2 93.8 95.8 96.0 94.6 96.7 
TCY 34.4 38.0 38.9 49.2 50.5 49.4 50.3 51.4 74.4 73.3 81.0 68.3 70.4 80.8 80.2 80.8 
CIP 50.8 53.2 61.5 69.2 70.3 74.7 76.6 74.3 83.7 86.7 88.9 87.7 91.5 90.9 91.9 91.7 
LEV 47.5 51.9 59.5 55.4 58.2 64.9 65.5 68.6 81.4 84.4 85.7 84.6 84.5 85.9 90.1 90.8 
GAT 42.6 44.3 48.8 53.8 54.9 58.4 62.1 62.9 69.8 68.9 82 69.2 70.4 72.7 72.1 75.0 
ERY 73.8 77.2 89.7 90.8 90.1 91.6 92.4 92.6 88.4 88.9 95.2 92.3 94.4 96.0 95.5 96.7 
VAN 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
TEC 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 
GEN 57.4 60.8 64.9 72.3 72.5 74.7 75.9 75.4 72.1 73.3 69.0 93.8 88.7 90.9 91.9 91.7 
RIF 65.6 69.6 71.3 75.4 76.9 77.3 77.2 77.7 69.8 71.1 76.2 76.9 77.5 78.8 79.3 79.2 
